Anmelden

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in mRNA is the presence of a premature stop codon. This is the result of sequence mutations that code for a Stop Codon prematurely in the reading frame. An estimated 30% of inherited genetic disorders in humans result from these mutations. These mRNAs are degraded in a pathway known as nonsense-mediated decay (NMD). NMD differs from other decay pathways by rapidly degrading mRNAs using 3′→5′ exonucleases.

Another prevalent decay mechanism detects lack of post-transcriptional modifications in mRNAs. RNA polymerase II transcripts are cotranscriptionally modified with a 5’ methylated G cap, and most of them have a chain of Adenine residues at the 3' end. Lack of either or both of these features, targets the mRNA for 5′→3′ exonucleolytic decay.

Other aberrations might be introduced if the mRNA has a single nucleotide mutation. Although this type of irregularity is most frequently observed in tRNAs, mRNAs can also be modified in the presence of reactive oxygen species (ROS), UV light, and alkylating agents. Chemical modifications caused by these agents are detected by NMD, non-stop decay (NSD) and no-go decay (NGD) pathways. All these pathways use specialized proteins that are sensitive to oxidative damage. These proteins recognize oxidized bases and direct the modified mRNAs to degradation pathways that use nucleases to digest the mRNAs.

While the degradation pathways discussed here target irregular mRNAs, they also down-regulate normal cellular mRNAs when they do not need to be translated. This process, formally classified as mRNA turnover, is also important to maintain optimum levels of mRNA in the cellular pool.

Tags
Nuclear ExportMRNAProtein SynthesisMature MRNANucleusCytoplasmNuclear Pore ComplexesNucleoporinsNuclear Transport ReceptorRNA receptor ComplexJunk RNAsPre spliced MRNAExcised IntronsSpliced ProductsTranscriptionPost transcriptional Processing5 Cap3 Poly A TailCap Binding ComplexCBCExon Junction ComplexEJCPolyA Binding ProteinsHeterogenous Nuclear Ribonuclear ProteinsHnRNPsSR Proteins

Aus Kapitel 8:

article

Now Playing

8.14 : Nukleärer Export von mRNA

Transkription: Von DNA zu RNA

7.4K Ansichten

article

8.1 : Was ist Genexpression?

Transkription: Von DNA zu RNA

25.3K Ansichten

article

8.2 : RNA-Struktur

Transkription: Von DNA zu RNA

23.1K Ansichten

article

8.3 : RNA-Stabilität

Transkription: Von DNA zu RNA

10.3K Ansichten

article

8.4 : Bakterielle RNA-Polymerase und Transkription

Transkription: Von DNA zu RNA

25.8K Ansichten

article

8.5 : Typen von RNA

Transkription: Von DNA zu RNA

23.0K Ansichten

article

8.6 : Transkription

Transkription: Von DNA zu RNA

33.8K Ansichten

article

8.7 : Transkriptionsfaktoren

Transkription: Von DNA zu RNA

19.5K Ansichten

article

8.8 : Eukaryotische RNA-Polymerasen

Transkription: Von DNA zu RNA

21.1K Ansichten

article

8.9 : RNA-Polymerase-II-Hilfs-Proteine

Transkription: Von DNA zu RNA

8.9K Ansichten

article

8.10 : Transkriptions-Elongationsfaktoren

Transkription: Von DNA zu RNA

10.5K Ansichten

article

8.11 : Prä-mRNA-Prozessierung

Transkription: Von DNA zu RNA

24.1K Ansichten

article

8.12 : RNA-Spleißen

Transkription: Von DNA zu RNA

16.7K Ansichten

article

8.13 : Chromatinstruktur reguliert prä-mRNA-Prozessierung

Transkription: Von DNA zu RNA

6.8K Ansichten

article

8.15 : Ribosomale RNA-Synthese

Transkription: Von DNA zu RNA

12.9K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten